Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials

Documenti analoghi

• Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
  di: Obieda Altobaishat, et al.
  Pubblicazione: (2025)
• Simplified Switching to Once‐Weekly Insulin Icodec Without an Initial One‐Time Additional Dose Versus Once‐Daily Insulin Glargine U100 in Basal Insulin‐Treated Type 2 Diabetes ( ONWARDS 10): A Randomised Controlled Trial
  di: Julio Rosenstock, et al.
  Pubblicazione: (2026)
• Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study
  di: Nobutoshi Fushimi, et al.
  Pubblicazione: (2025)
• Investigating the Correlation Between Cognitive Function and Fasting Blood Sugar, Fasting Insulin Level and Insulin Sensitivity in Patients With Multiple Sclerosis
  di: Nasim Rezaeimanesh, et al.
  Pubblicazione: (2024)
• Obesity as the Upstream Driver of Inflammation and Insulin Resistance in Hyperuricaemia
  di: Mohammad Riashad Monjur
  Pubblicazione: (2026)